Xilis
Durham · Founded 2019
About Xilis
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $111.4M
- Last round: Series Unknown (Apr 2025)
- Website: https://xilis.com/
- Phone: +1 984 377 6738
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/xilis-96879 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.